Decoding gene expression profiles of Hippo signaling pathway components in breast cancer
- PMID: 39928181
- DOI: 10.1007/s11033-025-10299-4
Decoding gene expression profiles of Hippo signaling pathway components in breast cancer
Abstract
Introduction: The Hippo signaling pathway is an evolutionarily conserved, tumor suppressor, stem cell pathway. This is the very less explored pathway in Breast Cancer. It is a crucial regulator of several biological processes, such as organ size, differentiation, tissue homeostasis, cellular proliferation, and stemness. Interestingly, deregulation of this pathway leads to tumorigenesis. Hence, the present study aims to identify the role of the Hippo signaling pathway in Breast Cancer.
Materials and methods: The mRNA expression of the Hippo signaling pathway molecules was evaluated in 120 pre-therapeutic patients by quantitative real-time PCR. Statistical analysis was carried out using SPSS 23. The association between the gene expression and clinicopathological parameters was analyzed by the paired sample t-test, and Pearson chi-square test. ROC curve analysis was carried out using Med Cal. A p-value of ≤ 0.05 was considered statistically significant.
Results: The hippo signaling pathway contains 10 core components i.e.SAV1, MOB1A, MOB1B, MST1, MST2, LATS1, LATS2, YAP, TAZ, and TEAD1 which were downregulated in malignant tissues as compared to adjacent normal tissue in breast cancer. In the correlation of hippo signaling pathway molecules with clinico pathological parameters, only LATS1, MST1, and SAV1 were found to be significantly negatively associated with stages of Breast Cancer. MOB1B was found to be significantly positively correlated with stages of Breast Cancer. ROC curve analysis of YAP, TAZ, LATS2, and TEAD showed significant discrimination between adjacent normal and malignant tissue.
Conclusion: In the current study, all the molecules of the hippo signaling pathway i.e. YAP, TAZ, LATS1, LATS2, MST1, MST2, SAV1, MOB1, MOB1B, TEAD1 were downregulated in BC suggesting the activation of hippo pathway which played a significant role in tumor suppression.
Keywords: Breast cancer; Clinico pathological parameter; Hippo signaling pathway; Real-Time PCR; TAZ; YAP.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Ethical approval: This study was approved by the GCRI/GCS Ethics Committee-BHR, The Gujarat Cancer and Research Institute, Asarwa, Ahmedabad 380016. GCRI/GCS Ethics Committee-BHR Reference number-EC/BHR/04/2021. Consent to participate: An informed consent was obtained from all the subjects prior to their enrolment in the study. Consent to publish: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Expression of hippo pathway in colorectal cancer.Saudi J Gastroenterol. 2014 May-Jun;20(3):188-94. doi: 10.4103/1319-3767.133025. Saudi J Gastroenterol. 2014. PMID: 24976283 Free PMC article.
-
WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.Mol Cell. 2022 May 19;82(10):1850-1864.e7. doi: 10.1016/j.molcel.2022.03.027. Epub 2022 Apr 15. Mol Cell. 2022. PMID: 35429439
-
Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.Oncotarget. 2015 Dec 29;6(42):44466-79. doi: 10.18632/oncotarget.6298. Oncotarget. 2015. PMID: 26561204 Free PMC article.
-
The emerging role of Hippo signaling pathway in regulating osteoclast formation.J Cell Physiol. 2018 Jun;233(6):4606-4617. doi: 10.1002/jcp.26372. Epub 2018 Jan 15. J Cell Physiol. 2018. PMID: 29219182 Review.
-
The Hippo pathway in intestinal regeneration and disease.Nat Rev Gastroenterol Hepatol. 2016 Jun;13(6):324-37. doi: 10.1038/nrgastro.2016.59. Epub 2016 May 5. Nat Rev Gastroenterol Hepatol. 2016. PMID: 27147489 Free PMC article. Review.
References
-
- Specht JM, Mankoff DA (2012) Advances in molecular imaging for breast cancer detection and characterization. Breast Cancer Res 14(2):206. https://doi.org/10.1186/bcr3094 - DOI - PubMed - PMC
-
- Demir Cetinkaya B, Biray Avci C (2022) Molecular perspective on targeted therapy in breast cancer: a review of current status. Med Oncol 39(10):149. https://doi.org/10.1007/s12032-022-01749-1 - DOI - PubMed - PMC
-
- Zhao B, Tumaneng K, Guan KL (2011) The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 13(8):877–883. https://doi.org/10.1038/ncb2303 - DOI - PubMed - PMC
-
- Snigdha K, Gangwani KS, Lapalikar GV, Singh A, Kango-Singh M (2019) Hippo Signaling in Cancer: lessons from Drosophila models. Front Cell Dev Biol 7:85. https://doi.org/10.3389/fcell.2019.00085 - DOI - PubMed - PMC
-
- Panciera T, Azzolin L, Cordenonsi M, Piccolo S (2017) Mechanobiology of YAP and TAZ in physiology and disease. Nat Rev Mol Cell Biol 18(12):758–770. https://doi.org/10.1038/nrm.2017.87 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous